Display Settings:

Format

Send to:

Choose Destination
J Med Chem. 2007 Dec 27;50(26):6725-9. Epub 2007 Dec 1.

Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.

Author information

  • 1Department of Medicinal Chemistry, University of Minnesota, Minneapolis 55455-0343, USA.

Abstract

A peptidomimetic of Pro-Leu-Pro-NH2, 7, possessing an indolizidinone type VI beta-turn mimic was synthesized via improved high-yielding protocols for the preparation and Cbz protection of alpha-allylproline. Bicyclic peptidomimetic 7 and spirobicylic peptidomimetic 8 enhanced the binding of [3H] N-propylnorapomorphine to dopamine receptors indicating that a type VI beta-turn is a possible bioactive conformation of the homochiral Pro-Leu-Pro-NH2 and Pro-Pro-Pro-NH 2 analogues of Pro-Leu-Gly-NH2 at the dopamine receptor allosteric regulatory site.

PMID:
18052024
[PubMed - indexed for MEDLINE]
PMCID:
PMC2529021
Free PMC Article

Images from this publication.See all images (7)Free text

Figure 1
Figure 2
Scheme 1
Scheme 2
Scheme 3
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk